Skip to content

Understanding Your Laboratory Test: What It Is, Why It Is Ordered, and What Your Results Mean

Published: August 9, 2026Updated: August 16, 2026

A genetic blood test that looks for mutations in the ABCD1 gene to diagnose X-linked adrenoleukodystrophy (X-ALD), a rare inherited disorder affecting the adrenal glands and nervous system.

Quick summary

{"The test analyzes your DNA from a blood sample to find changes (mutations) in the ABCD1 gene","It helps confirm diagnosis of X-linked adrenoleukodystrophy, a genetic disorder affecting adrenal function and brain white matter","Results typically take 2-4 weeks as the sample is sent to a specialized genetics laboratory","This test is recommended if you have symptoms or family history of X-ALD","Genetic counseling is often recommended before and after testing to understand results"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
53836-3
Short code
ABCD1 MUT
Synonyms
ABCD1 gene Mut Anl Bld/T
Category
chemistry
Sample
whole-blood
Container
EDTA tube (purple top) for whole blood
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
molgen
CPT
81401
SNOMED
129688006
Specimen volume
3-5 mL
Stability
Room temperature: 72 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): acceptable for extended storage
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
336–1008 hours
Order
routine

What is this test and what does it measure?

The ABCD1 gene targeted mutation analysis is a specialized genetic test that examines your DNA to find specific changes (mutations) in the ABCD1 gene. This gene provides instructions for making a protein that is essential for breaking down very long-chain fatty acids (VLCFAs). When the ABCD1 gene has a mutation, these fatty acids build up in the body, causing damage to the adrenal glands and the protective covering (myelin) of nerve cells in the brain.

Why might my healthcare provider order this test for me?

Your healthcare provider may order this test if you show symptoms suggestive of X-linked adrenoleukodystrophy (X-ALD), such as adrenal insufficiency (Addison's disease), progressive neurological problems including difficulty walking, vision loss, or cognitive changes. It may also be recommended if you have a family history of X-ALD, even if you don't have symptoms yet. Additionally, this test can be used for prenatal diagnosis or to confirm carrier status in women who might pass the gene to their children.

How is this test performed, and what can I expect during the procedure?

A healthcare professional will collect a blood sample from a vein in your arm using a small needle. The collection process only takes a few minutes and may cause minor discomfort or bruising at the puncture site. The blood sample is then sent to a specialized laboratory that performs molecular genetic testing. Technicians will extract DNA from your blood cells and analyze the ABCD1 gene for specific mutations known to cause X-ALD. The analysis uses techniques like polymerase chain reaction (PCR) and DNA sequencing to identify any genetic changes.

What do my test results mean, and how will my doctor interpret them?

A positive result means a mutation was found in the ABCD1 gene, confirming a diagnosis of X-linked adrenoleukodystrophy. This result helps guide treatment decisions and allows family members to understand their genetic risk. A negative result means no known disease-causing mutation was found; however, this does not completely rule out X-ALD if you have symptoms, as there may be rare mutations not detected by this specific test. Your healthcare provider and a genetic counselor will help you interpret your specific results in the context of your symptoms and family history.

Are there any risks, side effects, or limitations I should be aware of?

The blood draw itself carries minimal risks, including slight pain, bruising, or rare infection at the puncture site. The genetic test has some limitations: it may not detect all possible mutations in the ABCD1 gene, and sometimes variants of uncertain significance (VUS) are found whose effect on health is unknown. Results can also have implications for family members, which may cause emotional or psychological concerns. This is why genetic counseling is strongly recommended before and after testing.

Reference range

No pathogenic variant detected in ABCD1 geneN/A

Specimen: whole-blood

No special preparation required. Informed consent may be required per institutional policy. Clinical indication and family history should be provided.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

The ABCD1 gene mutation test is critical for diagnosing X-linked adrenoleukodystrophy, a peroxisomal disorder characterized by impaired breakdown of very long-chain fatty acids (VLCFAs). Elevated VLCFA levels cause progressive demyelination of neural white matter and adrenal insufficiency. Early diagnosis allows for timely intervention with adrenal hormone replacement therapy, dietary modifications (such as Lorenzo's oil), and monitoring for potentially life-threatening cerebral ALD. In affected males, the test confirms the diagnosis and guides family planning, while identifying female carriers has implications for offspring inheritance patterns. The specific mutation identified can sometimes provide prognostic information about disease severity and progression.

Frequently asked questions

How long does it take to get results?
Results typically take 2-4 weeks because the test requires specialized genetic analysis at a reference laboratory. Your healthcare provider will contact you when results are ready and may schedule a follow-up appointment to discuss them in detail.
Do I need to fast before this test?
No, fasting is not required for this genetic blood test. You can eat and drink normally before your blood draw. However, always follow any specific instructions given by your healthcare provider.
Can women have this test?
Yes, women can have this test. While X-ALD primarily affects males, women can be carriers of the ABCD1 gene mutation. Female carriers may sometimes develop mild symptoms. The test can determine if a woman carries the mutated gene, which is important for family planning decisions.
Will my insurance cover this genetic test?
Coverage varies by insurance plan. Many insurers cover genetic testing when it is medically necessary for diagnosis. It is recommended to check with your insurance company beforehand to understand your coverage and any out-of-pocket costs. Genetic counseling services may also be covered.
What happens if my test is positive?
A positive result confirms diagnosis of X-ALD. Your healthcare team will develop a treatment plan that may include hormone replacement therapy if adrenal function is affected, regular neurological monitoring, and dietary recommendations. Family members should also consider testing to determine their genetic status. Support resources and patient advocacy organizations can provide additional help.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy